---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-013744"
form_type: "8-K"
ticker: "RLYB"
cik: "0001739410"
company_name: "Rallybio Corp"
filed_at: "2022-08-02T23:59:59+00:00"
generated_at: "2026-06-24T06:01:44.213939+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Rallybio appoints Wendy K. Chung, M.D., Ph.D., to its Board of Directors

## Summary
- Board size increased from 9 to 10; Dr. Chung fills newly created vacancy effective Aug 1, 2022.
- Dr. Chung appointed as Class III director with term expiring at 2024 annual meeting.
- She will serve on the Nominating and Corporate Governance Committee.
- Compensation follows standard non-employee director policy; no material transactions disclosed.

## SEC filing metadata
- accession: 0000950170-22-013744
- form_type: 8-K
- ticker: RLYB
- cik: 0001739410
- company_name: Rallybio Corp
- filed_at: 2022-08-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/0000950170-22-013744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/rlyb-20220801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-013744
- JSON: https://secwatch.observer/filing/0000950170-22-013744.json
- Plain text: https://secwatch.observer/filing/0000950170-22-013744.txt

## Key facts
- Executive change
  Wendy K. Chung, M.D., Ph.D. was appointed as director at Rallybio Corp.
  - Action: appointed
  - Role: director
  source text: the Board increased its size from nine directors to ten directors and appointed Wendy K. Chung, M.D., Ph.D. to serve as a director to fill the newly created vacancy, effective August 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/0000950170-22-013744-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.